Fatigue in cancer: A review of literature

Indian Journal of Palliative Care

Volumn 15, Issue 1, 2009, Pages 19-25

  Narayanan, Vijayakumar ^a   Koshy, Cherian ^b  

^a St Gregorios Medical Mission Hospital   (India)

^b REGIONAL CANCER CENTRE   (India)

Author keywords

Chemotherapy; Fatigue; Palliation; Radiotherapy

Indexed keywords

EID: 68349146152     PISSN: 09731075     EISSN: 19983735     Source Type: Journal    
DOI: 10.4103/0973-1075.53507     Document Type: Review

References (83)

1. National comprehensive cancer net work, American Cancer Society (2008) Cancer related fatigue and anemia, treatment guidelines for patients, Version I. Available from: http://www.cancer.org. [cited in 2008].
2. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 2003;362:640-66.
3. Portoney RK, Itri LM. Cancer related fatigue: Guidelines for evaluation and management. Oncologist 1994;4:1-10.
4. Wagner LI, Cella D. Fatigue and cancer: Causes, prevalence and treatment approaches . Br J Cancer 2004;91:822-8.
5. Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S. Fatigue associated with cancer and its treatment. Support Care Cancer 2002;10:389-98.
6. Radbruch L, Strasser F, Elsner F, Gonçalves JF, Løge J, Kaasa S, et al. Fatigue in palliative care patients. Palliat Med 2008;22:13-32.
7. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, et al. Patient, caregiver and oncologist perceptions of cancer -related fatigue: Results of a tri-part assessment survey .Semin Haematol 1997;34:4-12.
8. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Ann Oncol 2000;11:971-5.
9. Reem E, Richardson A. Fatigue: A concept analysis. Int J Nurs Stud 1996;33:519-29.
10. Piper B. Fatigue. In: Carrieri V, Lindsey A, West C, editors. Pathophysiological phenomena in Nursing: Human responses to illness. 2nd ed. Philadelphia: Saunders; 1993. p. 279-302
11. Carpentio LJ. Fatigue. In: Carpentio LJ, editor. Nursing diagnosis: Applications to clinical practice. 6th ed. Philadelphia: Lippincot Company; 1995. p. 379.
12. Cella D, Davis K, Breibart W, Curt G. Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385-91.
13. Murphy H, Alexander S, Stone P. Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: A feasibility study. Palliat Med 2006;20:413-18.
14. Fernandez R, Stone P, Andrews P, Morgan R, Sharma S. Comparison between fatigue, sleep disturbance and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer related fatigue. J Pain Symptom Manage 2006;32:245-54.
15. Smets EM, Garssen B, Bonke B, de Haes JC. The multidimensional fatigue Inventory: Psychometric qualities of an instrument to assess fatigue. J Psychsom Res 1995;39:315-25.
16. Radbruch L, Strasser F, Elsner F, Gonçalves JF, Løge J, Kaasa S, et al. Fatigue in palliative care patients: An EAPC approach. Palliat Med 2008;22:13-32.
17. Smets EM, Garssen B, Schuster-Uittenhoeve AL, de Haes JC. Fatigue in cancer patients. Br J Cancer 1993;68:220-4.
18. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients. Cancer 1999;85:1186-96.
19. Stone P. The measurement, causes and effective management of cancer-related fatigue. Int J Palliat Nurs 2002;8:120-8.
20. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004;32:40-50.
21. Stone P, Richards M, A?Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000;11:561-7.
22. Krupp LB. Fatigue in multiple sclerosis. CNS Drugs 2003;17:225-34.
23. Goodlin SJ. Palliative care for end stage heart failure. Curr Heart Fail Rep 2005;2:155-60.
24. Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The health care needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med 2005;19:485-91.
25. Breitbart W, McDonald M V, Rosenfeld B, Monkmann ND, Passik S. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage 1998;15:159-67.
26. Cardenas DD, Kutner NG. The problem of fatigue in dialysis patients. Nephron 1982;30:336-40
27. Wysenbeek AJ, Leibovici L, Weinberger A, Guedj D. Fatigue in systemic lupus erythematosus. Br J Rheumatol 1993;32:633-5.
28. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17.
29. Woof R. Asthenia cachexia and anorexia. In: Faull C, et al., editors. Handbook of Palliative care. Oxford: Blackwell Sciences; 1998. p. 272-83.
30. Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue and cytokine levels in patients with acute myelogenous leukaemia or myelodysplastic syndrome. Cancer 2005;104:788-93.
31. Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M. Treatment-r elated fatigue and serum Interleukin-I levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 1993;8:196-200.
32. Gulstein HB. The biologic basis of fatigue. Cancer 2001;92:1678-83.
33. Bower JE, Ganz PA, Dickerson SS, Peterson L, Aziz N, Fahey JL. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005;30:92-100.
34. Beach P, Siebeneck B, Buderer NF, Ferner T. Relationship between fatigue and nutritional status in patients receiving radiation therapy to treat lung cancer. Oncol Nurs Forum 2001;28:1027-31.
35. Glause A. Fatigue in patients with cancer: Analysis and assessment, vol.145. Recent results in cancer research. Springer-Verlag; Berlin: 1998.
36. Moore G, Hayes C. Maintenance of comfort (fatigue and pain). In: Watkins- Bruner D, Moore-Higgs G, Haas M, editors. Outcomes in radiation therapy: multidisciplinary management .Jones and Bartlett, Massachusets: 2001. p. 459-92.
37. Cella D, Dobrez D, Glaspy J. Control of cancer-related anemia with erythropoetic agents: A review of evidence for improved quality of life and clinical outcomes. Ann Oncol 2003;14:511-9.
38. Stone PC, Abdul Wahab A, Gibson JS, Wright RJ, Andrews PL. Fatigue in cancer patients is not related to changes in oxyhemoglobin dissociation. Support Care Cancer 2005;13:854-8.
39. Curran SL, Beacham AO, Andrykowsky MA. Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med 2004;27:425-44.
40. Servaes P, Verhagen C, Bleigenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002;38:27-43.
41. Gelinas C, Fillion L. Factors related to persistent fatigue following completion of breast cancer treatment. Oncol Nurs Forum 2004;31:269-77.
42. Blesch KS, Paice JA, Wickham R, Harte N, Schnoor DK, Purl S, et al. Correlates of fatigue in people with lung and breast cancer. Oncol Nurs Forum 1991;18:81-7.
43. Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 1986;4:805-14.
44. Faithful S. Supportive care in radiotherapy: Evaluating the potential contribution of nursing: Institute of Cancer Research. London: London University; 2000. p. 294.
45. Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 1998;25:915-20.
46. Piper B, Dodd M. Self initiated fatigue interventions and their perceived effectiveness. Oncol Nurs Forum 1991;18:39
47. Meek PM, Nail LM, Barsevick A, Schwartz AL, Stephen S, Whitmer K, et al. Psychometric testing of fatigue instruments for use with cancer patients. Nursing Res 2000;49:181-9.
48. Glaus A. Fatigue in patients with cancer: Analysis and assessment. Cancer Res 1998;145:1-172.
49. Smets EM, Garssen B, Bonke B, De Haes JC. The multi-dimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-25.
50. Cella D. Manual of the functional assessment of chronic illness therapy (FACIT). Measurement system. Evanston, Ill. Center on Outcomes, Research and Education (CORE) 1997.
51. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper fatigue scale: Psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998;25:677-84.
52. Bruera K, Kuehn N, Miller MJ, Selmser P, Macmillan K. () The Edmonton symptom assessment system (ESAS) J Palliat Care 1991;7:6-9
53. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton symptom assessment scale. Cancer 2000;88:2164-71.
54. Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM. Thalidomide in the treatment of cancer cahexia: A randomised placebo controlled trial. Gut 2005;54:540-5.
55. Goldberg RM, Loprinzi CL, Mailliard JA, O'Fallon JR, Krook JE, Ghosh C, et al. Pentoxyfyllin for treatment of cancer anorexia and cachexia? A randomised, double blind, placebo-controlled trial. J Clin Oncol 1995;13:2856-9
56. World Health Organisation. Cancer Pain relief, 2nd ed. Geneva: World health Organisation; 1996.
57. Drueke TB, Locatelli F, Clyne N. Normalisation of haemoglobin level in patient with chronic kidney disease and anaemia. N Engl J Med 2006;355:2071-84.
58. Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997;14:328-31.
59. Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J, et al. Effectiveness of megestrol acetate in patients with advanced cancer. Cancer Prev Control 1998;2:74-8.
60. De Conno F, Martini C, Zecca E, Balzarini A, Venturino P, Groff L, et al. Megestrol acetate for anorexia in patients with far advanced cancer: A double blind controlled clinical trial. Eur J Cancer 1998;34:1705-9.
61. Westman G, Bergman B, Albertsson M, Kadar L, Gustavsson G, Thaning L, et al. Megestrol acetate in advanced, progressive, hormone insensitive cancer: Effects on the quality of life: A placebo controlled, randomised, multicentric trial. Eur J Cancer 1999;35:586-95.
62. Lander M, Wilson K, Chochinov HM. Depression and the dying older patient. Clin Geriatr Med 2000;16:335-56.
63. Kasper S, de Swart H, Friis Anderson H. Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry 2005;13:884-91.
64. Sarhill N, Walsh D, Nelson KA, Homsi J, Le Grand S, Davis M P. Methyl phenidate for fatigue in advanced cancer: A prospective open-label private study. Am J Palliat Care 2001;18:403-7.
65. Homsi J, Walsh D, Nelson KA, Legrand S, Davis M. Methyl phenidate for depression in hospice practice: A case series. Am J Palliat Care 2000;17:393-8.
66. Wilwerding MB, Loprinzi CL, Mailliard JA, O'Fallon JR, Miser AW, van Haelst C, et al. A randomised, cross over evaluation of methyl phenidate in cancer patients receiving strong narcotics. Support Care Cancer 1995;3:135-8.
67. Bruera E, Chadwick S, Brenneis C, Hanson J, Mac Donald RN. Methyl phenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 1987;71:67-70.
68. Bruera E, Valero V, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, et al. Patient controlled methyl phenidate for the management of fatigue in patients with advanced cancer: A double blind randomised placebo -controlled trial. J Clin Oncol 2003;24:2073-8.
69. Slatkin NE, Rhiner M. Treatment of opiate-related sedation: Utility of the cholinesterase inhibitors. J Support Oncol 2003;1:53-63.
70. Bruera E, Roca E, Cedaro L, Carraro S, Chakon R. Action of oral methyl prednisolone in terminal cancer patients .Cancer Treat Rep 1985;69:751-4.
71. Hardy JR, Rees E, Ling J, Burman R, Feuer D, Broadley K, et al. A prospective survey for the use of dexamathasone on a palliative care unit. Palliat Med 2001;15:3-8.
72. Rabkin JG, Mc Elhiney MC, Rabkin R, Ferrando SJ. Modafnil treatment for fatigue in HIV + patients: a pilot study. J Clin Psychiatry 2004;65:1688-95.
73. Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, et al. Modafnil for fatigue in Multiple Sclerosis: a randomised placebo -controlled double blind study. Neurology 2005;64:1139-43.
74. Ondo WG, Fayle R, Atassi F, Jankovic J. Modafnil for day time somnolence in Parkinson's disease: double blind placebo-controlled parallel trial.J Neurol Neurosurg Psychiatry 2005;76:1636-9.
75. Krishnasamy M. Exploring the nature and impact of fatigue in advanced cancer. Int J Palliat Nurs 1997;3:126-31.
76. Mock V, Hassey-Dow K, Meares C, Grimm PM, Dienemann JA, Haisfeld-Wolfe ME, et al. Effects of exercise on fatigue, physical functioning and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:991-9.
77. Pearce S, Richardson A. Fatigue and cancer: a phenomenological study. J Cancer Nurs 1994;3:381-2.
78. Faithfull S. Fatigue and radiotherapy. In: Faithfull S, Weils M, editors. Supportive care in Radiotherapy.London: Churchill Livingstone; 2003. p. 126-9.
79. Winningham ML. Strategies for managing cancer-related fatigue syndrome. Cancer 2001;92:988-97.
80. Oldervol LM, Loge JH, Paltiel H, Asp MB, Vidvei U, Wiken AN, et al. The effect of a physical exercise programme in palliative care. J Pain Symptom Manage 2006;31:421-30.
81. Cimprich B. Development of an intervention to restore attention in cancer patients. Cancer Nursing 1993;16:82-92.
82. Fillion L, Gagnon P, Leblond F, Gélinas C, Savard J, Dupuis R, et al. A brief intervention for fatigue management in breast cancer survivors. Cancer Nursing 2008;31:145-58.
83. Trijsberg R, van Knippenberg F, Rijpma S. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 1992;54:489-517.